RedHill Biopharma Initiates Co-Promotion of HIV/AIDS Anti-Diarrheal Drug Mytesi® Pharmaceutical Investing
Corbus Pharmaceuticals to Commence Phase 3 Study of Lenabasum for the Treatment of Rare Autoimmune Disease Dermatomyositis Pharmaceutical Investing
Rubius Therapeutics to Acquire Manufacturing Facility in Smithfield, Rhode Island to Produce Red Cell Therapeutics Biotech Investing
EyeGate Announces FDA Approval of Two IDE Submissions for Ocular Bandage Gel Pharmaceutical Investing
Sienna Biopharmaceuticals Completes Maximal Use Safety Study of SNA-120 in Patients with Itch Associated with Psoriasis Biotech Investing
Positive Final Results Returned from Phase 2 Clinical Trials using Satipharm Capsules Cannabis Investing News
Rhythm Pharmaceuticals Receives European Medicines Agency PRIME Designation for Setmelanotide in Rare Genetic Disorders of Obesity Pharmaceutical Investing
Adamis Pharmaceuticals Adds Sublingual Erectile Dysfunction Product Candidate to its Pipeline Pharmaceutical Investing
Corbus Pharmaceuticals Receives FDA Orphan Drug Designation for Lenabasum for the Treatment of Dermatomyositis Pharmaceutical Investing
